Equities

ADM Tronics Unlimited Inc

ADMT:QBB

ADM Tronics Unlimited Inc

Actions
  • Price (USD)0.0763
  • Today's Change-0.004 / -4.69%
  • Shares traded150.00
  • 1 Year change-31.61%
  • Beta0.0687
Data delayed at least 15 minutes, as of Oct 08 2024 17:39 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ADM Tronics Unlimited, Inc. is a technology-based developer and manufacturer of diversified lines of products. The Company has three areas of activity: proprietary medical devices; medical device design, engineering, regulatory and manufacturing services, and eco-friendly, water-based formulations. Its segments include Chemical, Electronics and Engineering. It develops and manufactures electronic technologies for non-invasive, electrotherapeutic and diagnostic medical devices as well as for veterinary and other applications. The Company develops and manufactures its own proprietary products as well as on a contract basis for other companies. It develops, manufactures, and sells chemical products to industrial users. Its products include water-based primers and adhesives, water-based coatings and resins, water-based chemical additives, and anti-static conductive paints, coating and other products. The Company has developed several medical and cosmetic topical products.

  • Revenue in USD (TTM)3.06m
  • Net income in USD-472.80k
  • Incorporated1969
  • Employees7.00
  • Location
    ADM Tronics Unlimited Inc224 S Pegasus AveNORTHVALE 07647United StatesUSA
  • Phone+1 (201) 767-6040
  • Fax+1 (201) 784-0620
  • Websitehttps://www.admtronics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Telesis Bio Inc16.28m-50.12m3.98m137.00------0.2445-29.66-30.689.615.610.19473.153.40118,832.10-57.15---64.21--49.47---293.54--1.72-52.960.356--0.2697---1.14------
Optimus Healthcare Services Inc1.89m-7.16m4.03m12.00------2.13-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
BioSig Technologies Inc40.00k-18.08m4.12m4.00------103.08-1.97-1.970.00410.00660.0112--1.0710,000.00-489.14-269.73-4,711.71-363.1165.00---43,760.00-24,485.73---3,115.670.00---93.71---6.52---9.58--
Predictive Oncology Inc1.75m-14.04m4.30m34.00--0.8997--2.46-3.36-3.360.41580.71710.11081.454.2851,425.29-88.98-91.80-121.17-126.2960.2364.64-802.93-1,419.991.37--0.0634--18.244.7545.67--5.44--
Caduceus Software Systems Corp0.00-117.60k4.35m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Sharps Technology Inc0.00-8.21m4.38m3.00--0.6069-----0.4944-0.49440.000.25240.00-------75.56---100.97----------0.6446--0.00-------112.12------
Kelyniam Global Inc517.70k-420.28k4.39m0.00--8.11--8.48-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Encision Inc6.56m-529.29k4.63m22.00--2.49--0.7056-0.045-0.0450.5560.15661.702.107.59298,337.30-13.69-3.03-19.50-4.1349.0051.25-8.06-1.891.01-8.890.1761---10.38-5.64-113.55---9.54--
Hawkeye Systems Inc0.00-578.72k4.79m44.00---------0.093-0.0930.00-0.30060.00-------117.01-314.04-----------195.39---1.49--------52.81------
Nu-Med Plus Inc0.00-112.13k4.87m2.00---------0.0014-0.00140.00-0.00220.00----0.00-471.23-447.69---------------21.34--------3.56------
Reflect Scientific Inc1.73m-53.09k5.05m7.00--2.5765.622.92-0.0006-0.00060.02030.0230.71970.846317.05247,638.60-2.2011.10-2.5913.2158.1962.48-3.0610.005.68--0.00---47.09-6.99-613.46------
ADM Tronics Unlimited Inc3.06m-472.80k5.15m7.00--5.05--1.68-0.007-0.0070.04530.01511.113.725.67---17.14-15.22-29.35-22.0942.8741.15-15.45-18.580.8954--0.3259---19.35-0.3572-810.74------
Biomerica Inc5.41m-5.98m5.33m63.00--0.8091--0.9851-0.3554-0.35540.32180.39180.45662.176.4985,920.63-50.43-44.68-61.13-51.7311.2314.11-110.44-63.822.43--0.00--1.420.810916.27---7.64--
Dror Ortho-Design Inc0.00-5.63m5.35m4.00--3.23-----0.012-0.0120.000.00340.00-------577.48-140.50-1,394.24---------118,188.00----0.00-------1,896.02------
Aethlon Medical, Inc.0.00-11.50m5.53m14.00--0.6351-----3.87-3.870.000.62510.00----0.00-84.49-76.25-98.84-85.78-------2,246.87----0.00---100.00---1.43------
Biotricity Inc12.24m-18.28m5.61m55.00------0.4585-1.74-1.741.18-1.272.121.678.08222,624.00-248.61-269.25----71.8958.93-117.41-258.940.106-0.6408----25.1597.8223.57------
Data as of Oct 08 2024. Currency figures normalised to ADM Tronics Unlimited Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.